Page 5 - ஃபைப்ரோஸிஸ் புதியது ஜீலாந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஃபைப்ரோஸிஸ் புதியது ஜீலாந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஃபைப்ரோஸிஸ் புதியது ஜீலாந்து Today - Breaking & Trending Today

Tauranga boy pleads for Trikafta drug to ease cystic fibrosis

Tauranga boy pleads for Trikafta drug to ease cystic fibrosis
19 Feb, 2021 10:00 PM
7 minutes to read
Harry Oxenham has cystic fibrosis and hopes a treatment drug will change his life. Photo / George Novak
Harry Oxenham has cystic fibrosis and hopes a treatment drug will change his life. Photo / George Novak
It s a little like the sound of a dishwasher or the
washing machine.
The sound is relentless - constantly filling the silence
of thought as Harry s parents, Aly, Dan and I talk.
Ironically, relentless is how Aly describes the half-hour treatment regime that sees Harry using three different mouthpieces, to achieve three different results for the sticky mucus on his lungs, otherwise known as cystic fibrosis. ....

New Zealand , New Zealanders , Jane Bollard , Harry Oxenham , Rotorua Leah Rumney , Lisa Williams , Leah Rumney , Rotorua Daily Post Weekend , Fibrosis New Zealand , Cystic Fibrosis New Zealand , Trikafta For Kiwis , Harry S , புதியது ஜீலாந்து , ஜேன் பொல்லார்ட் , லிசா வில்லியம்ஸ் , லியா ரம்னி , ஃபைப்ரோஸிஸ் புதியது ஜீலாந்து , சிஸ்டிக் ஃபைப்ரோஸிஸ் புதியது ஜீலாந்து , ஹாரி கள் ,

Levels of IgG antibodies may influence COVID-19 outcomes

Levels of IgG antibodies may influence COVID-19 outcomes
COVID-19, the source of the current pandemic, may be caused by a single virus, but it has a variety of presentations that make treatment difficult. Children, for example, almost exclusively experience mild or asymptomatic COVID-19, while adults can develop severe or even fatal COVID-19.
But children who contract COVID-19 are at risk for a rare but serious syndrome called multisystem inflammatory syndrome in children (MIS-C). Severe cases of MIS-C can lead to cardiac disease and ventricular failure, and require hospitalization and intense medical support.
Researchers Galit Alter, Ph.D., a core member of the Ragon Institute of MGH, MIT and Harvard, and Lael Yonker, MD, director of the Massachusetts General Hospital Cystic Fibrosis Center, are working to understand why COVID-19 can lead to such distinctly different outcomes in different populations. ....

United States , Yannic Bartsch , Lael Yonker , Emily Henderson , Ragon Institute , Harvard Medical School , Hospital Cystic Fibrosis Center , Department Of Infectious Diseases , Galit Alter , Nature Medicine , Infectious Diseases , Study First Author , Research Fellow , Cystic Fibrosis , Immune Response , Immune System , Medical School , ஒன்றுபட்டது மாநிலங்களில் , லேல் யொண்கேர் , எமிலி ஹென்டர்சன் , ராகன் நிறுவனம் , ஹார்வர்ட் மருத்துவ பள்ளி , மருத்துவமனை சிஸ்டிக் ஃபைப்ரோஸிஸ் மையம் , துறை ஆஃப் தொற்று நோய்கள் , இயற்கை மருந்து , தொற்று நோய்கள் ,

Study sheds light on pathological characteristics behind sudden cardiac death

Study sheds light on pathological characteristics behind sudden cardiac death
Nearly a half-million people a year die from sudden cardiac death (SCD) in the U.S. the result of malfunctions in the heart s electrical system.
A leading cause of SCD in young athletes is arrhythmogenic cardiomyopathy (ACM), a genetic disease in which healthy heart muscle is replaced over time by scar tissue (fibrosis) and fat.
Stephen Chelko, an assistant professor of biomedical sciences at the Florida State University College of Medicine, has developed a better understanding of the pathological characteristics behind the disease, as well as promising avenues for prevention. His findings are published in the current issue of ....

Stephen Chelko , Emily Henderson , Florida State University , National Research Council In Padova , College Of Medicine , Professor Of Biomedical Sciences , Florida State University College Of Medicine , Florida State University College , Science Translational , Assistant Professor , Biomedical Sciences , Florida State , National Research Council , Sudden Cardiac Death , Cell Death , எமிலி ஹென்டர்சன் , புளோரிடா நிலை பல்கலைக்கழகம் , தேசிய ஆராய்ச்சி சபை இல் ப்யாடோவ , கல்லூரி ஆஃப் மருந்து , ப்ரொஃபெஸர் ஆஃப் உயிர் மருத்துவ அறிவியல் , புளோரிடா நிலை பல்கலைக்கழகம் கல்லூரி ஆஃப் மருந்து , புளோரிடா நிலை பல்கலைக்கழகம் கல்லூரி , அறிவியல் மொழிபெயர்ப்பு , உதவியாளர் ப்ரொஃபெஸர் , உயிர் மருத்துவ அறிவியல் , புளோரிடா நிலை ,

Study highlights the epigenetics of life at high altitudes

Study highlights the epigenetics of life at high altitudes
Humans inhabit an incredible range of environments across the globe, from arid deserts to frozen tundra, tropical rainforests, and some of the highest peaks on Earth. Indigenous populations that have lived in these extreme environments for thousands of years have adapted to confront the unique challenges that they present.
Approximately 2% of people worldwide live permanently at high altitudes of over 2,500 meters (1.5 miles), where oxygen is sparse, UV radiation is high, and temperatures are low. Native Andeans, Tibetans, Mongolians, and Ethiopians exhibit adaptations that improve their ability to survive such conditions. Andeans, for example, display increased chest circumference, elevated oxygen saturation, and a low hypoxic ventilatory response, enabling them to thrive at exceptionally high elevations. ....

Cerro De Pasco , United States , Ainash Childebayeva , Emily Henderson , Cayetano Heredia University , Department Of Archaeogenetics , University Of Michigan , Genome Biology , Wide Epigenetic Signatures , Adaptive Developmental Plasticity , Peruvian Quechua , Andean Altiplano , Cerro De Pasco High Altitude , Max Planck Institute , Human History , Central Asia , Dna Methylation , சிஇஆர்ஆர்ஓ டி பாஸ்கோ , ஒன்றுபட்டது மாநிலங்களில் , எமிலி ஹென்டர்சன் , கேயேதானோ பரம்பரை பல்கலைக்கழகம் , பல்கலைக்கழகம் ஆஃப் மிச்சிகன் , மரபணு உயிரியல் , பரந்த எபிஜெனெடிக் கையொப்பங்கள் , பெருவியன் க்வ்ய்க்ஃப்வா , சிஇஆர்ஆர்ஓ டி பாஸ்கோ உயர் உயரம் ,

Study: Cytoglobin drug could delay the progression of liver fibrosis in mice

Researchers have discovered that the use of Cytoglobin (CYGB) as an intravenous drug could delay liver fibrosis progression in mice. ....

Thanh Thuy , Norifumi Kawada , Emily Henderson , Osaka City University , Professor Norifumi Kawada , Study Senior Author , Osaka City , Liver Disease , த்யாந் த்ுய் , எமிலி ஹென்டர்சன் , ஒசகக நகரம் பல்கலைக்கழகம் , படிப்பு மூத்தவர் நூலாசிரியர் , ஒசகக நகரம் , கல்லீரல் நோய் ,